Solventum Co. (NYSE:SOLV) Stake Lowered by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS trimmed its position in shares of Solventum Co. (NYSE:SOLV) by 2.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,386 shares of the company’s stock after selling 692 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Solventum were worth $1,941,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Modus Advisors LLC bought a new stake in Solventum in the fourth quarter worth approximately $25,000. Stonebridge Financial Group LLC bought a new stake in Solventum in the fourth quarter worth $26,000. Crews Bank & Trust acquired a new position in Solventum during the fourth quarter worth $32,000. True Wealth Design LLC increased its position in Solventum by 23,550.0% during the third quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after buying an additional 471 shares during the last quarter. Finally, Synergy Asset Management LLC bought a new position in Solventum during the fourth quarter valued at about $35,000.

Analyst Ratings Changes

A number of brokerages have recently commented on SOLV. Bank of America increased their price objective on Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a report on Wednesday, February 26th. Mizuho increased their price target on Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a report on Monday, March 3rd. Morgan Stanley boosted their price objective on shares of Solventum from $73.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Wednesday, March 5th. Piper Sandler upped their price objective on shares of Solventum from $75.00 to $84.00 and gave the stock a “neutral” rating in a report on Friday, February 28th. Finally, The Goldman Sachs Group lifted their target price on shares of Solventum from $63.00 to $71.00 and gave the stock a “sell” rating in a report on Monday, March 3rd. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat, Solventum presently has an average rating of “Hold” and a consensus target price of $79.86.

Solventum Price Performance

Shares of Solventum stock opened at $74.87 on Wednesday. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The company has a market cap of $12.95 billion and a PE ratio of 27.23. The firm has a fifty day moving average price of $75.38 and a two-hundred day moving average price of $71.73. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $85.92.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.